Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
The objective of this study was to investigate the influence of talc and triethyl citrate (TEC) on stabilizing the drug release rates following curing and storage at elevated temperature of pellets coated with an aqueous acrylic polymeric dispersion. Core pellets containing anhydrous theophylline (20%), microcrystalline cellulose, and polyvinylpyrrolidone were prepared by extrusion-spheronization. The aqueous dispersions were prepared by adding up to 30% TEC as a plasticizer and talc up to 200% as an antiadherent to a mixture of Eudragit RS 30D/RL 30D (95:5). The theophylline pellets were coated in a fluidized-bed coating unit and then cured at elevated temperatures. Theophylline pellets were successfully coated with the Eudragit dispersions that contained up to 200% talc, based on the dry polymer weight, and the coating efficiency was greater than 93%. Our results demonstrated that the polymer, which was plasticized by TEC, was able to function as a film-forming agent for dispersions containing high levels of talc. No sticking of the coated pellets was observed during the coating process or during the curing or equilibrating phase, even with high levels of TEC in the film. The dissolution rate of theophylline from the coated pellets was delayed when the film coating dispersion contained high levels of talc. Additionally, the stability of the drug release profiles from the coated pellets after storage was significantly improved. Furthermore, a modified dissolution testing used to simulate mechanical stresses that may be encountered in vivo showed the film coated pellets would have sufficient strength. The results of this study demonstrated that high levels of film additives in the acrylic dispersion contributed to the stabilization of the drug release rates as well as the reproducibility of the coating process.
Maejima
T
T
College of Pharmacy, University of Texas at Austin, Austin, TX 78712, USA. maejima@tanabe.co.jp
McGinity
J W
JW
D000180:Acrylic Resins / Q000008:administration & dosage*; D002951:Citrates / Q000008:administration & dosage*; D004355:Drug Stability; D012995:Solubility; D013627:Talc / Q000008:administration & dosage*; D013678:Technology, Pharmaceutical; D013806:Theophylline / Q000008:administration & dosage / Q000737:chemistry
D000180:Acrylic Resins; D002951:Citrates; D013627:Talc; C050528:Eudragit RS; C023001:ethyl citrate; D013806:Theophylline